PHENERGAN Drug Patent Profile
✉ Email this page to a colleague
When do Phenergan patents expire, and what generic alternatives are available?
Phenergan is a drug marketed by Wyeth Ayerst, Mylan, Delcor Asset Corp, and Ani Pharms. and is included in six NDAs.
The generic ingredient in PHENERGAN is codeine phosphate; promethazine hydrochloride. There are nineteen drug master file entries for this compound. Eight suppliers are listed for this compound. Additional details are available on the codeine phosphate; promethazine hydrochloride profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for PHENERGAN?
- What are the global sales for PHENERGAN?
- What is Average Wholesale Price for PHENERGAN?
Summary for PHENERGAN
| US Patents: | 0 |
| Applicants: | 4 |
| NDAs: | 6 |
| Raw Ingredient (Bulk) Api Vendors: | 123 |
| Clinical Trials: | 17 |
| Patent Applications: | 2,670 |
| Formulation / Manufacturing: | see details |
| Drug Prices: | Drug price information for PHENERGAN |
| DailyMed Link: | PHENERGAN at DailyMed |
Recent Clinical Trials for PHENERGAN
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| University of Colorado, Denver | Phase 4 |
| University of Florida | Phase 4 |
| South Valley University | Phase 1 |
US Patents and Regulatory Information for PHENERGAN
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Wyeth Ayerst | PHENERGAN | promethazine hydrochloride | INJECTABLE;INJECTION | 008857-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Delcor Asset Corp | PHENERGAN | promethazine hydrochloride | TABLET;ORAL | 007935-003 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Mylan | PHENERGAN | promethazine hydrochloride | SUPPOSITORY;RECTAL | 010926-001 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Delcor Asset Corp | PHENERGAN | promethazine hydrochloride | TABLET;ORAL | 007935-004 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Wyeth Ayerst | PHENERGAN | promethazine hydrochloride | INJECTABLE;INJECTION | 008857-003 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Mylan | PHENERGAN | promethazine hydrochloride | SUPPOSITORY;RECTAL | 010926-002 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Delcor Asset Corp | PHENERGAN | promethazine hydrochloride | TABLET;ORAL | 007935-002 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
